2020 American Heart Association Scientific Sessions*

November 13-17, 2020; Virtual Conference
Review the latest data in managing heart failure with Capsule Summaries and an expert-authored commentary covering key studies from AHA 2020.

Highlights

Capsule Summary Slidesets

Omecamtiv mecarbil associated with decreased risk of a composite of heart failure events and cardiovascular death but not individual components of this endpoint.

Released: November 16, 2020

In patients with iron deficiency, FCM reduced risk of HFH with no apparent effect on risk of CV death.

Released: November 18, 2020

High-dose trivalent influenza vaccine was comparable to standard-dose quadrivalent vaccine regarding deaths or cardiopulmonary hospitalizations.

Released: November 20, 2020

Risk of CV death or hospitalization for HF was highest in patients with hospitalization for HF within 3 months prior to study.

Released: November 18, 2020
Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Merck

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue